AZ Q4 '17 Earnings Update
Here is a brief preview of this blast: AZ hosted their Q4 '17 earnings call (press release) and briefly discussed their diabetes portfolio, with a particular focus on Farxiga and Bydureon.
Here is a brief preview of this blast: AZ hosted their Q4 '17 earnings call (press release) and briefly discussed their diabetes portfolio, with a particular focus on Farxiga and Bydureon.